Search Results - "Candır, Burcu Aslan"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease by Aslan Candır, Burcu, Yiğenoğlu, Tuğçe Nur, Kızıl Çakar, Merih, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Journal of oncology pharmacy practice (01-06-2022)
    “…Introduction Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic cell transplantation (HCT). In the treatment of chronic…”
    Get full text
    Journal Article
  2. 2

    Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities by Aslan Candır, Burcu, Yiğenoğlu, Tuğçe Nur, Kızıl Çakar, Merih, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Journal of oncology pharmacy practice (01-06-2022)
    “…Introduction The most common kind of leukemia in adults is chronic lymphocytic leukemia (CLL). CLL is treated with ibrutinib. During the course of ibrutinib…”
    Get full text
    Journal Article
  3. 3

    Evaluation of oral manifestations and head and neck lymphadenopathy in newly diagnosed acute leukemia patients by Pamukcu, Umut, Dal, Mehmet Sinan, Yaman, Samet, Aslan Candır, Burcu, Bozan, Ersin, Secilmis, Sema, Acik Kemaloglu, Sibel, Altuntas, Fevzi, Peker, Ilkay

    Published in Special care in dentistry (01-05-2024)
    “…Objectives To determine the frequency of head and neck lymphadenopathy (LAP) and intraoral findings (non‐dental/dental) in patients with newly diagnosed acute…”
    Get full text
    Journal Article
  4. 4

    Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting by Namdaroğlu, Sinem, Başcı, Semih, Aslan Candır, Burcu, Yaman, Samet, Yiğenoğlu, Tuğçe Nur, Bahsi, Taha, Özcan, Nurgül, Dal, Mehmet Sinan, Kızıl Çakar, Merih, Altuntaş, Fevzi

    Published in Journal of clinical medicine (30-08-2024)
    “…: The Wilms' tumor gene 1 (WT1) plays a critical role in cell development and the regulation of essential genes involved in cell growth and metabolism. In the…”
    Get full text
    Journal Article
  5. 5

    Is an earlier strategy for harvesting peripheral blood stem cells in healthy allogeneic donors feasible? by Yaman, Samet, Bozan, Ersin, Seçilmiş, Sema, Candır, Burcu Aslan, Kılınç, Ali, Başcı, Semih, Yiğenoğlu, Tuğçe Nur, Çakar, Merih Kızıl, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Transfusion and apheresis science (01-08-2024)
    “…Peripheral blood stem cells (PBSC) mobilization with granulocyte colony stimulating factor (G-CSF) for healthy donors is generally performed at 5th day…”
    Get full text
    Journal Article
  6. 6

    MDS-663 When Treating Myelodysplastic Syndrome (MDS), How Successful is Luspatercept? by Bozan, Ersin, Candir, Burcu Aslan, Yaman, Samet, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…MDS is a hematological disease with complications and affects quality of life. Luspatercept has a positive effect on both hematological parameters and quality…”
    Get full text
    Journal Article
  7. 7
  8. 8

    ABCL-669 Glofitamab in Relapsed Refractory Diffuse Large B-Cell Lymphoma: Single Center Experience by Yaman, Samet, Candir, Burcu Aslan, Bozan, Ersin, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…Glofitamab is a bispecific T-cell-engaging antibody that is bivalent for CD20 on B cells and monovalent for CD3 on T cells. Clinical trials are ongoing as a…”
    Get full text
    Journal Article
  9. 9

    CT-089 Acute Graft-Versus-Host Disease (GVHD) of the Heart Is an Emergency by Candir, Burcu Aslan, Yaman, Samet, Bozan, Ersin, Yiğenoğlu, Tuğçe Nur, Çakar, Merih Kizil, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…Acute GVHD is a common complication of allogeneic hematopoietic cell transplantation (HCT) and is characterized by organ damage, inflammation, and dysfunction…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage? by Cengiz, Mustafa, Candır, Burcu Aslan, Yılmaz, Güldal, Akyol, Gülen, Ozenirler, Seren

    Published in World journal of gastroenterology : WJG (14-11-2013)
    “…To evaluate the red cell distribution width (RDW) as an indicator of the presence of non-alcoholic steatohepatitis (NASH) and its association with fibrotic…”
    Get full text
    Journal Article
  12. 12

    Early Tapering of Cyclosporine Is Feasible in Haploidentical Stem Cell Transplantation: A Single Center Experience by Yaman, Samet, Başci, Semih, Bozan, Ersin, Seçilmiş, Sema, Candir, Burcu Aslan, Yiğenoğlu, Tuğçe Nur, Çakar, Merih Kızıl, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Clinical transplantation (01-06-2024)
    “…ABSTRACT Introduction Cyclosporine‐A (CsA) and post transplantation cyclophosphamide (PTCy) are common agents used for graft versus host disease (GVHD)…”
    Get full text
    Journal Article